Determining the Time to Maximal Bronchodilator Response in Asthmatic Children

References

• Miller M R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten C P, Gustafsson P, Jensen R, Johnson D C, MacIntyre N, McKay R, Navajas D, Pedersen O F, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005; 26: 319–338
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, Crapo R O, Burgos F, Casaburi R, Coates A, van der Grinten C P, Gustafsson P, Hankinson J, Jensen R, Johnson D C, MacIntyre N, McKay R, Miller M R, Navajas D, Pedersen O F, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968
   PubMed Web of Science ®Google Scholar
• Borg B M, Reid D W, Walters E H, Johns D P. Bronchodilator reversibility testing: Laboratory practices in Australia and New Zealand. Med J Aust 2004; 180: 610–613
   PubMed Web of Science ®Google Scholar
• Hall G L, Gain K R. Standardization of lung function testing: Current practices in laboratories in Australia and New Zealand. Respirology 2006; 11: 511–512
   PubMedGoogle Scholar
• Brand P L, Quanjer P H, Postma D S, Kerstjens H A, Koeter G H, Dekhuijzen P N, Sluiter H J. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch chronic non-specific lung disease study group. Thorax 1992; 47: 429–436
   PubMed Web of Science ®Google Scholar
• Chhabra S K, Vijayan V K, Gupta R, De S. Expression of bronchodilator response: Comparison of four indices. Respir Med 2002; 96: 611–614
   PubMed Web of Science ®Google Scholar
• Kerstjens H A, Brand P L, Quanjer P H, van der Bruggen-Bogaarts B A, Koeter G H, Postma D S. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD study group. Thorax 1993; 48: 722–729
   PubMed Web of Science ®Google Scholar
• Ouksel H, Meslier N, Badatcheff-Coat A, Racineux J-L. Influence of predicted fev1 on bronchodilator response in asthmatic patients. Respiration 2003; 70: 54–59
   PubMedGoogle Scholar
• Quadrelli S A, Roncoroni A J, Montiel G C. Evaluation of bronchodilator response in patients with airway obstruction. Respir Med 1999; 93: 630–636
   PubMed Web of Science ®Google Scholar
• Waalkens H J, Merkus P J, van Essen-Zandvliet E E, Brand P L, Gerritsen J, Duiverman E J, Kerrebijn K F, Knol K K, Quanjer P H. Assessment of bronchodilator response in children with asthma. Dutch CNSLD study group. Eur Respir J 1993; 6: 645–651
   PubMed Web of Science ®Google Scholar
• Choo-Kang Y F, Simpson W T, Grant I W. Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma. BMJ 1969; 2: 287–289
   PubMed Web of Science ®Google Scholar
• Heath J R. How long do you wait after salbutamol?. Inspire 2003, August:18
   Google Scholar
• Kemp J P, Hill M R, Vaughan L M, Meltzer E O, Welch M J, Ostrom N K. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler. Ann Allergy Asthma Immunol 1997; 79: 322–326
   PubMedGoogle Scholar
• Riding W D, Dinda P, Chatterjee S S. The bronchodilator and cardiac effects of five pressure-packed aerosols in asthma. Br J Dis Chest 1970; 64: 37–45
   PubMedGoogle Scholar
• Seberova E, Andersson A. Oxis (formoterol given by turbuhaler) showed as rapid an onset of action as salbutamol given by a pmdi. Respir Med 2000; 94: 607–611
   PubMed Web of Science ®Google Scholar
• Sykes A P, Ayres J G. A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma. Respir Med 1990; 84: 135–138
   PubMed Web of Science ®Google Scholar
• Wallin A, Sandstrom T, Rosenhall L, Melander B. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Thorax 1993; 48: 611–614
   PubMed Web of Science ®Google Scholar
• Lotvall J, Lunde H, Svedmyr N. Onset of bronchodilation and finger tremor induced by salmeterol and salbutamol in asthmatic patients. Can Respir J 1998; 5: 191–194
   PubMedGoogle Scholar
• Matera M G, Cazzola M, Vinciguerra A, Di Perna F, Calderaro F, Caputi M, Rossi F. A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease. Pulm Pharmacol 1995; 8: 267–271
   PubMedGoogle Scholar
• Grimwood K, Johnson-Barrett J J, Taylor B. Salbutamol: Tablets, inhalational powder, or nebuliser?. Br Med J (Clin Res Ed) 1981; 282: 105–106
   PubMedGoogle Scholar
• Asthma management handbook 2006. National Asthma Council Australia, Melbourne 2006
   Google Scholar
• Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA). 2006
   Google Scholar
• Razzouk H, dos Santos L, Giudicelli J, Queiros M, de Lurdes Chieira M, Castro A, Ramos C, Lindbladh C. A comparison of the bronchodilatory effect of 50 and 100 microg salbutamol via turbuhaler and 100 microg salbutamol via pressurized metered dose inhaler in children with stable asthma. Int J Pharm 1999; 180: 169–175
   PubMedGoogle Scholar
• Barbato A, Cracco A, Tormena F, Novello A, Jr. The first 20 minutes after a single dose of inhaled salmeterol in asthmatic children. Allergy 1995; 50: 506–510
   PubMedGoogle Scholar
• Schuh S, Johnson D W, Stephens D, Callahan S, Winders P, Canny G J. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr 1999; 135: 22–27
   PubMed Web of Science ®Google Scholar
• Pierart F, Wildhaber J H, Vrancken I, Devadason S G, Le Souef P N. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999; 13: 673–678
   PubMed Web of Science ®Google Scholar
• Wildhaber J H, Waterer G W, Hall G L, Summers Q A. Reducing electrostatic charge on spacer devices and bronchodilator response. Br J Clin Pharmacol 2000; 50: 277–280
   PubMed Web of Science ®Google Scholar
• Knudson R J, Lebowitz M D, Holberg C J, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725–734
   PubMed Web of Science ®Google Scholar
• Paton J Y. A practical approach to the interpretation of lung function testing in children. Paediatr Respir Rev 2000; 1: 241–248
   PubMedGoogle Scholar